Poly ADP-ribose polymerase (PARP) inhibitors - new therapeutic strategies in Acute Myeloid Leukemia: a literature review
The use of poly (ADP-ribose) polymerase (PARP) inhibitors has recently increased as a result of demonstrating their superior efficacy compared to traditional chemotherapy in various cancer subtypes in many preclinical studies and clinical trials. A better understanding of the molecular mechanisms o...
Main Authors: | Emilia Nowicka, Michał Obel, Kinga Panuciak, Angelika Mastalerczyk, Kamila Czyżak, Jan Lejman, Karolina Makowska, Wiktor Wiśniewski |
---|---|
Format: | Article |
Language: | English |
Published: |
Kazimierz Wielki University
2022-12-01
|
Series: | Journal of Education, Health and Sport |
Subjects: | |
Online Access: | https://apcz.umk.pl/JEHS/article/view/41206 |
Similar Items
-
Myelodysplastic Syndrome/Acute Myeloid Leukemia Following the Use of Poly-ADP Ribose Polymerase (PARP) Inhibitors: A Real-World Analysis of Postmarketing Surveillance Data
by: Quanfeng Zhao, et al.
Published: (2022-06-01) -
Corrigendum: Myelodysplastic syndrome/acute myeloid leukemia following the use of poly-ADP ribose polymerase inhibitors: A real-world analysis of postmarketing surveillance data
by: Quanfeng Zhao, et al.
Published: (2022-08-01) -
Targeting PARP proteins in acute leukemia: DNA damage response inhibition and therapeutic strategies
by: Antonella Padella, et al.
Published: (2022-01-01) -
The Association between PARP1 and LIG3 Expression Levels and Chromosomal Translocations in Acute Myeloid Leukemia Patients
by: Hossein Pashaiefar, et al.
Published: (2018-04-01) -
Clinical Application of Poly(ADP-ribose) Polymerase (PARP) Inhibitors in Prostate Cancer
by: Andrisha-Jade Inderjeeth, et al.
Published: (2022-11-01)